funding history / development milestones

战略投资，融资金额未公开

2019.12.20, 泰格医药, 盈科资本, 高瓴资本

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

生物科技/生物工程

抗体

生物制药

疫苗

制药/药业

重组疫苗

人用疫苗

生物医药

医药

疫苗技术

生命科学

药物研发

生物制品

银发经济

医药工业

People who follow this company also follow

Competitors (Similar Companies)

Follow in Bulk Copy Company Names

维亚生物科技（上海）股份有限公司

“使命：成为全球创新型生物科技公司的摇篮。”

Mabwell (Shanghai) Bioscience Co., Ltd.

“Research and development of innovative macromolecular drugs such as th”

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

“Research, development, and production of anti-tumor and surgical medic”

Shanghai Kehua Bio-engineering Co., Ltd.

“A leading enterprise in China's in-vitro clinical diagnostics industry”

上海和元生物技术（集团）股份有限公司

“赋能基因治疗，共守生命健康”

Zhejiang WOLWO Bio-Pharmaceutical Co., Ltd.

“Products for the diagnosis and treatment of allergic diseases”

Shanghai Henlius Biotech, Inc.

“Research and development and industrialization of monoclonal antibody ”

Shanghai Bluewood Chemical Co., Ltd.

“High-quality life science reagents”

Shanghai InnoStar Bio-Tech Co., Ltd.

“New drug safety evaluation research institution”

Nanjing GenScript Biotech Co., Ltd.

生物科技/生物工程医药基因合成生物医药

GlaxoSmithKline (China) Investment Co., Ltd.

“We are a science-led global healthcare company”

Shanghai Smacon Biotechnology Co., Ltd.

医药生物科技/生物工程生产医药工程

Seebio Biotechnology (Shanghai) Co., Ltd.

生物科技/生物工程医药生命科学生物制品

南京中生联合股份有限公司

“全球营养健康管理专家”

Shanghai Zesheng Technology Development Joint-stock Co., Ltd.

抗肿瘤药肿瘤药物肿瘤疫苗新药研发

中 中文版 View this page in Chinese ›